Search for: "In Re: Fosamax Products Liability Litigation"
Results 61 - 80
of 95
Sorted by Relevance
|
Sort by Date
21 Feb 2014, 8:53 am
” In re Fosamax Products Liability Litigation, 2013 WL 174416, at *1 (S.D.N.Y. [read post]
22 Aug 2014, 9:22 am
In In re Avandia Marketing, Sales Practices & Products Liability Litigation, 817 F. [read post]
2 Dec 2011, 2:00 pm
Stryker Corp., 631 F.3d 777, 782 (5th Cir. 2011); In re Fosamax Products Liability Litigation, 2011 WL 5903623, at *7 (D.N.J. [read post]
13 May 2010, 12:27 pm
Implantable Defibrillators Products Liability Litigation, 2009 WL 1921902 (D. [read post]
17 Aug 2011, 5:00 am
In re Fosamax Products Liability Litigation, 694 F. [read post]
28 Dec 2012, 1:57 pm
We did, and we’re back just in time for our favorite (and nearly last) post of the year, our choices for the best prescription medical product liability decisions of 2012. [read post]
1 May 2014, 4:59 am
So we read the decision in In re: Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation (Gannon), No. 3:13-cv-10143-DRH-PMF, 2014 U.S. [read post]
29 Apr 2014, 1:13 pm
More Blog Posts: Fosamax Plaintiff Receives $285,000 Verdict After Jury Trial, Pharmacy Error Injury Lawyer Blog, February 12, 2013 Pharmaceutical Company Allegedly Knew of Harmful Fosamax Side Effects as Far Back as 2004, According to Review of Internal Documents: In Re: Fosamax Products Liability Litigation, Pharmacy Error Injury Lawyer Blog, December 5, 2012 Fosamax Lawsuit in New York May Proceed, but With Limitations,… [read post]
7 Nov 2014, 5:52 am
SeeRestatement (Third) of Torts, Products Liability §2, reporters notes to comment l (1998). [read post]
2 Sep 2010, 1:16 pm
In re Fosamax Products Liability Litigation, 2008 WL 2940560, at *7 (S.D.N.Y. [read post]
25 Feb 2012, 10:04 am
Litig., 2000 WL 1222042 (E.D.Pa. 2000) Fosamax In re Fosamax Prods. [read post]
13 Aug 2015, 10:56 am
Once approved, “major changes” to the labeling of a pharmaceutical product again require FDA preapproval. [read post]
6 Oct 2010, 5:56 am
District Court, Southern DistrictProducts Liability Award Reduced From $8 Million to $1.5 Million, Attorney Sanctioned in Anti-Osteoporosis Drug Case In Re: Fosamax Products Liability Litigation, 06-MD-1789-JFK FREE WITH REGISTRATIONAPPELLATE TERMLandlord/Tenant LawPanel Reverses Order That Ruled Self-Help Not Available to Landlord to Regain PossessionSol De Ibiza LLC v. [read post]
1 Feb 2013, 9:42 am
Back in May, 2010 we first applied that description to In re Gadolinium-Based Contrast Agents Products Liability Litigation, 2010 WL 1796334 (N.D. [read post]
5 Mar 2012, 12:24 pm
In In re Fosamax Products Liability Litigation, 694 F. [read post]
31 Dec 2014, 5:00 am
We’re celebrating the new year in our usual style, with our annual top ten best prescription medical product liability litigation decisions of 2014. [read post]
27 Oct 2011, 4:24 am
Dec. 9, 2009)(“a jury must determine whether a reasonable person would attach significance to the off-label use of [the medical device] before deciding whether to undergo the surgery in this case”); In re Diet Drug Litigation, 384 N.J. [read post]
29 Dec 2010, 12:54 pm
Stick a fork in economic loss class actions derivative of supposed product liability defects – they’re done. [read post]
16 May 2012, 12:22 pm
Feb. 13, 2012); In re Pamidronate Products Liability Litigation, ___ F. [read post]
5 Apr 2012, 11:54 am
Feb. 23, 2012) (express warranty); In re Pamidronate Products Liability Litigation, ___ F. [read post]
